suscept
canin
popul
could
prevent
rabi
transmiss
among
canin
face
technic
logist
challeng
canin
requir
annual
rabi
vaccin
month
age
often
develop
adequ
protect
immun
due
poor
immunogen
vaccin
use
coexist
malnutrit
diseas
huge
number
rapid
turnov
freeroam
canin
difficulti
retriev
booster
vaccin
introduc
addit
layer
complex
canin
vaccin
programm
develop
countri
clearli
potent
inexpens
vaccin
effici
mass
vaccin
strategi
need
hour
canin
rabi
control
rabiesendem
countri
plasmidbas
vaccin
explor
altern
cell
culturebas
rabi
vaccin
anim
prophylaxi
eukaryot
express
vector
encod
fulllength
glycoprotein
gene
rabi
viru
repres
simplest
design
antirabi
vaccin
capabl
gener
protect
neutral
antibodi
upon
vivo
deliveri
construct
shown
mediat
effici
prophylaxi
small
anim
model
observ
poorli
immunogen
larger
anim
refer
therein
gener
system
labil
poor
cellular
uptak
low
immunogen
remain
major
hurdl
limit
util
plasmid
vivo
applic
attempt
improv
plasmidbas
vaccin
current
focus
improv
vector
design
gene
modif
use
effici
deliveri
vehicl
molecular
adjuv
deliveri
approach
employ
gene
gun
electropor
cation
lipid
microparticl
nanopolym
evalu
improv
plasmidrais
immun
respons
molecular
adjuv
form
gene
fragment
code
immunomodulatori
molecul
also
employ
plasmid
vaccin
enhanc
immunogen
efficaci
attempt
gener
employ
coadministr
discret
plasmid
encod
immunogen
gene
adjuv
construct
design
fusion
two
molecul
could
advantag
achiev
sitespecif
adjuv
limit
adjuv
toxic
varieti
cytokin
chemokin
proapoptot
gene
report
effect
adjuv
plasmidbas
vaccin
tolllik
receptor
tlr
group
evolutionarili
conserv
pattern
recognit
receptor
express
wide
varieti
immun
nonimmun
cell
sens
specif
pathogen
ligand
initi
inflammatori
immun
signal
cascad
ligand
signal
intermediari
hold
consider
promis
immunomodulatori
agent
tlr
ligand
need
present
extracellularli
bind
cognat
receptor
requir
increas
risk
nonspecif
interact
system
toxic
advers
event
tlr
adaptor
molecul
howev
act
within
cell
limit
possibl
toxic
quickli
achiev
threshold
level
faster
kinet
myeloid
differenti
factor
adaptor
molecul
essenti
signal
tlr
except
also
role
signal
interleukin
il
receptor
pathway
studi
report
critic
role
signal
tlr
pathway
gener
vaccinegener
humor
immun
takeshita
et
al
report
enhanc
immunogen
protect
efficaci
plasmidbas
influenza
vaccin
upon
use
genet
adjuv
tlr
adaptor
molecul
investig
previous
adjuv
potenti
plasmid
vaccin
rabi
present
work
evalu
genet
adjuv
candid
plasmid
rabi
vaccin
report
effect
immunogen
protect
efficaci
vaccin
swiss
albino
mice
babi
hamster
kidney
atcc
obtain
nation
centr
cell
scienc
pune
india
maintain
eagl
minimum
essenti
medium
supplement
fetal
bovin
serum
european
grade
fb
biolog
industri
beit
haemek
israel
antibiot
uml
penicillin
streptomycin
sigma
aldrich
st
loui
mo
usa
bicistron
eukaryot
express
vector
pire
provid
dr
praveen
k
gupta
indian
veterinari
research
institut
izatnagar
uttar
pradesh
india
contain
bp
fragment
human
myeloid
differenti
factor
primari
respons
gene
kind
gift
dr
fumihiko
takeshita
yokohama
citi
univers
school
medicin
japan
develop
piresrgp
encod
glycoprotein
gene
rabi
viru
report
us
earlier
murin
monoclon
antibodi
rabi
viru
glycoprotein
produc
part
earlier
project
use
indirect
immunofluoresc
stain
procedur
glycoprotein
express
express
probe
polyclon
rabbit
antibodi
cat
cell
signal
technolog
danver
usa
secondari
antibodi
conjug
goat
antimous
iggfitc
cat
goat
antirabbit
iggtritc
cat
purchas
merck
bioscienc
mumbai
india
inhous
antirabi
serum
calibr
second
intern
refer
serum
obtain
nation
institut
biolog
standard
hertfordshir
uk
employ
refer
serum
rapid
fluoresc
focu
inhibit
test
rffit
standard
laboratori
fix
strain
challeng
viru
standard
rabi
viru
obtain
freezedri
mous
brain
prepar
central
research
institut
kasauli
india
maintain
passag
cell
suckl
mice
employ
vitro
anim
experi
commerci
rabi
vaccin
rabipur
pcec
vaccin
bno
chiron
behr
vaccin
pvt
ltd
ankleshwar
india
potenc
iuml
use
control
immunogen
plan
anim
experi
approv
institut
anim
ethic
committe
nimhan
b
nv
date
swiss
albino
mice
week
age
either
sex
use
vivo
studi
care
anim
experiment
procedur
perform
guidelin
institut
anim
ethic
committe
fig
show
schemat
represent
propos
plasmid
vaccin
construct
fulllength
glycoprotein
gene
g
pcr
amplifi
vector
use
primer
gfor
attagctagcatggttcctcaggctctcc
grev
atgtagaattctcac
agtctggtctgac
bear
nhei
mlui
site
respect
subclon
restrict
site
multipl
clone
sitea
pire
vector
report
earlier
construct
name
piresrgp
bp
fragment
human
gene
similarli
subclon
multipl
clone
siteb
piresrgp
briefli
gene
fragment
pcr
amplifi
use
mydfor
attatctacaatggctgcaggaggtccc
mydrev
primer
taaagtcgactcagggcagggacaaggc
bear
xbai
sali
site
respect
use
templat
reaction
set
volum
employ
pmol
mydfor
mydrev
unit
pfu
dna
polymeras
ng
templat
amplif
condit
follow
denatur
minut
follow
cycl
second
second
second
final
extens
minut
amplicon
gelpurifi
use
genelut
gel
extract
kit
sigma
aldrich
quantit
sequenti
restrict
digest
pire
vector
amplicon
perform
xbai
sali
enzym
digest
gelpurifi
ligat
reaction
set
vector
insert
ratio
use
dna
ligas
thermo
scientif
volum
overnight
incub
reaction
mixtur
use
transform
compet
escherichia
coli
cell
standard
heatshock
procedur
transform
subsequ
identifi
select
luria
bertani
lb
ampicillin
agar
plate
ident
recombin
verifi
coloni
pcr
use
mydfor
mydrev
primer
glycerol
stock
recombin
made
store
till
use
ident
recombin
construct
verifi
restrict
enzym
analysi
nucleotid
sequenc
data
shown
express
gene
encod
piresrgp
piresrgpmyd
evalu
indirect
immunofluoresc
stain
cell
transient
transfect
evalu
g
express
piresrgp
report
earlier
evalu
express
g
gene
piresrgpmyd
transient
transfect
experi
set
cell
use
plasmid
fourtyeight
hour
posttransfect
cell
acetonefix
subject
indirect
immunofluoresc
stain
protein
stain
glycoprotein
express
perform
done
previous
verifi
express
cell
probe
rabbit
polyclon
antibodi
dilut
phosphat
buffer
salin
pb
ph
follow
goat
antirabbit
iggtritc
conjug
dilut
pb
ph
coverslip
examin
invert
fluoresc
microscop
nikon
tokyo
japan
imag
obtain
help
digit
camera
glycerol
stock
plasmid
construct
thaw
streak
lb
ampicillin
agar
plate
overnight
incub
singl
coloni
transfer
steril
inocul
loop
ml
lb
ampicillin
broth
incub
hour
starter
cultur
subsequ
inocul
ml
fresh
lb
ampicillin
broth
grown
vigor
shake
rpm
overnight
inocul
l
fresh
lb
ampicillin
broth
incub
similar
condit
hour
growth
bacteria
pellet
centrifug
rpm
plasmid
ident
verifi
restrict
enzym
analysi
plasmid
miniprep
made
ml
overnight
cultur
largescal
purif
plasmid
perform
bacteri
pellet
use
commerci
kit
endofre
plasmid
purif
giga
kit
qiagen
per
manufactur
instruct
qualiti
concentr
plasmid
prepar
evalu
spectrophotometri
agaros
electrophoresi
prepar
store
aliquot
till
use
group
swiss
albino
mice
either
sex
employ
experi
nineti
microgram
plasmid
contain
steril
normal
salin
inocul
intramuscularli
intraderm
respect
anim
intramuscular
immun
administ
quadricep
muscl
left
leg
intraderm
inocul
done
point
cm
base
tail
anim
receiv
one
dose
immunogen
day
control
group
inocul
cell
cultur
rabi
vaccin
http
wwwecevrorg
http
dx
rabipur
steril
normal
salin
empti
pire
vector
blood
sampl
collect
immun
mice
retroorbit
venou
plexu
punctur
halothan
anesthesia
day
first
immun
sampl
allow
clot
sera
separ
centrifug
rpm
minut
sera
heatinactiv
water
bath
minut
store
till
test
rabi
viru
neutral
antibodi
rvna
titr
sera
assay
standard
rffit
modif
mice
subject
intracerebr
challeng
strain
rabi
viru
day
anim
observ
period
day
rabiesspecif
symptom
end
observ
period
percent
surviv
group
record
anim
show
symptom
rabi
euthan
infect
confirm
direct
fluoresc
antibodi
test
impress
smear
prepar
extract
brain
statist
analys
done
use
graphpad
prism
softwar
version
graphpad
softwar
san
diego
ca
usa
comparison
antibodi
titr
differ
group
perform
nonparametr
anova
test
follow
posthoc
analysi
tukey
multipl
comparison
test
p
consid
statist
signific
develop
evalu
construct
piresrgp
encod
fulllength
rabi
glycoprotein
gene
report
earlier
fragment
bp
success
amplifi
pcr
clone
mcsb
piresrgp
restrict
site
xbai
sali
yield
construct
piresrgpmyd
presenc
g
gene
insert
construct
check
pcr
use
genespecif
primer
fig
verifi
restrict
enzym
analysi
nucleotid
sequenc
data
shown
express
g
piresrgp
cell
transient
transfect
piresrgp
reveal
express
glycoprotein
upon
indirect
immunofluoresc
stain
use
glycoproteinspecif
monoclon
antibodi
report
earlier
indirect
immunofluoresc
stain
use
specif
antibodi
reveal
express
g
protein
cell
transfect
piresrgpmyd
transfect
cell
show
typic
applegreen
membran
cytoplasm
fluoresc
indic
glycoprotein
express
orang
tritc
fluoresc
indic
express
observ
cell
membran
cytoplasm
field
indic
probabl
coloc
protein
fig
order
prepar
milligram
amount
plasmid
requir
ed
immun
experi
use
commerci
largescal
endotoxinfre
plasmid
purif
kit
per
manufactur
instruct
collect
sera
mice
day
postimmun
estim
rvna
titr
rffit
result
singl
repres
experi
summar
tabl
seen
tabl
rvna
titr
iuml
indic
seroconvers
rabi
develop
day
group
mice
immun
piresrgp
piresrgpmyd
observ
highest
rvna
titr
group
receiv
two
dose
rabipur
iuml
follow
group
immun
piresrgpmyd
iuml
notabl
piresrgpmyd
induc
fold
higher
level
antibodi
piresrgp
p
time
point
rvna
titr
increas
group
booster
dose
day
tabl
day
highest
titr
neutral
antibodi
still
seen
rabipur
group
iuml
mice
immun
piresrgpmyd
show
mean
titr
iuml
mean
titr
observ
group
immun
piresrgp
point
iuml
rvna
titr
increas
group
follow
booster
dose
day
rvna
titr
follow
intramuscular
immun
piresrgpmyd
higher
induc
piresrgp
point
p
among
intraderm
immun
group
highest
rvna
titr
day
detect
group
immun
rabipur
iuml
tabl
piresrgpmyd
piresrgp
induc
titr
iuml
respect
time
point
observ
increas
rvna
titr
follow
booster
piresrgpmyd
wherea
piresrgp
booster
increa
ed
evalu
protect
efficaci
plasmid
construct
intracerebr
challeng
studi
strain
rabi
viru
day
inocul
anim
observ
period
day
clinic
symptom
rabi
percentag
surviv
record
group
mice
inocul
empti
vector
pire
normal
salin
develop
clinic
symptom
rabi
day
euthan
observ
surviv
rate
group
immun
intramuscularli
piresrgp
fig
notabl
piresrgpmyd
protect
anim
follow
intramuscular
intraderm
immun
piresrgp
howev
protect
mice
follow
immun
via
either
rout
anim
immun
rabipur
surviv
challeng
valu
present
standard
deviat
rvna
titr
limit
detect
rapid
fluoresc
focu
inhibit
test
group
despit
success
demonstr
efficaci
plasmid
dnabas
vaccin
strategi
rabi
number
anim
model
technolog
still
constrain
poor
immunogen
observ
larger
anim
delay
onset
antibodi
respons
number
physic
chemic
biolog
method
develop
evalu
enhanc
dna
vaccin
efficaci
vivo
electropor
gene
gun
deliveri
found
yield
highest
efficaci
neutral
antibodi
direct
surfac
protein
pathogen
repres
crucial
correl
protect
immun
number
infect
includ
rabi
gener
prolifer
antibodysecret
plasma
bcell
mainten
antigenspecif
memori
bcell
underli
effici
longlast
humor
immun
respons
signal
molecul
tlr
pathway
offer
opportun
influenc
phenomena
view
ubiquit
express
abil
modul
multipl
signal
pathway
experiment
evid
abound
abil
influenc
immun
inflammatori
signal
multipl
pathway
protect
immun
mani
pathogen
view
report
suggest
import
role
play
signal
gener
humor
immun
respons
explor
potenti
util
genet
adjuv
plasmid
vaccin
rabi
studi
reveal
coexpress
plasmid
rabi
vaccin
enhanc
rvna
titr
swiss
albino
mice
upon
intramuscular
intraderm
immun
tabl
notabl
mean
rvna
titr
day
higher
group
immun
intramuscularli
piresrgpmyd
group
immun
piresrgp
p
agreement
takeshita
et
al
report
enhanc
antibodi
titr
upon
adjuv
plasmid
vaccin
influenza
piresrgpmyd
increas
rvna
titr
upon
intraderm
immun
compar
piresrgp
p
observ
compar
antibodi
titr
group
receiv
piresrgp
intramuscularli
intraderm
observ
intrigu
known
intraderm
immun
gener
induc
better
immun
respons
intramuscular
immun
previou
studi
pinto
et
al
studi
effect
coadministr
plasmid
encod
chemokin
cytokin
gene
rant
tranc
plasmid
vaccin
rabi
observ
modest
adjuv
effect
secret
truncat
form
protein
author
comment
genet
adjuv
may
unabl
influenc
earli
event
immun
respons
due
tempor
differ
express
immunogen
adjuv
gene
present
studi
contrast
evalu
immun
respons
plasmid
coexpress
viral
glycoprotein
gene
coexpress
gene
appreci
fluorescentlystain
transfect
cell
would
seem
like
express
could
influenc
activ
matur
antigen
present
cell
site
inocul
earli
onset
high
initi
titr
rvna
would
ideal
context
rabi
vaccin
wherea
former
hold
critic
import
postexposur
prophylaxi
declin
antibodi
respons
nonprotect
level
delay
high
initi
titr
rvna
would
benefici
maintain
protect
immun
long
period
immun
anim
especi
canin
find
studi
appear
suggest
abil
adjuv
influenc
two
relev
attribut
protect
immun
rabi
evalu
protect
efficaci
vaccin
formul
viral
challeng
studi
perform
immun
anim
day
piresrgp
protect
immun
anim
challeng
follow
intramuscular
intraderm
rout
administr
notabl
anim
immun
piresrgpmyd
either
rout
surviv
challeng
fig
kaur
et
al
report
variat
protect
efficaci
viral
challeng
despit
similar
magnitud
immun
respons
differ
plasmid
vaccin
construct
suggest
probabl
contribut
cellular
immun
factor
protect
immun
rabi
find
present
studi
seem
support
complet
protect
lethal
viru
challeng
observ
group
immun
piresrgp
propos
enhanc
rvna
respons
protect
efficaci
follow
immun
piresrgpmyd
might
result
stimul
cellular
immun
respons
conclus
studi
reveal
genet
adjuv
consider
enhanc
protect
immun
respons
plasmidbas
rabi
vaccin
plasmid
vaccin
encod
addit
protect
immunogen
http
wwwecevrorg
http
might
repres
efficaci
vaccin
candid
gener
longlast
protect
immun
rabi
infecti
diseas
especi
immun
anim
need
evalu
field
condit
